再生障碍性贫血晚期移植物失败后第二次清髓性异基因造血干细胞移植长期存活者中的Ser245Tyr TINF2突变 - Suppr

Suppr

超能文献

Ser245Tyr TINF2 mutation in a long-term survivor after a second myeloablative SCT following late graft failure for Aplastic Anaemia.

作者信息

Miano Maurizio, Lanciotti Marina, Giardino Stefano, Dufour Carlo

机构信息

Haematology Unit, G. Gaslini Children's Hospital, Genoa, Italy.

出版信息

Blood Cells Mol Dis. 2015 Aug;55(2):187-8. doi: 10.1016/j.bcmd.2015.01.002. Epub 2015 Jan 17.

DOI:10.1016/j.bcmd.2015.01.002

PMID:25616367

Abstract

摘要

相似文献

Ser245Tyr TINF2 mutation in a long-term survivor after a second myeloablative SCT following late graft failure for Aplastic Anaemia.再生障碍性贫血晚期移植物失败后第二次清髓性异基因造血干细胞移植长期存活者中的Ser245Tyr TINF2突变

Blood Cells Mol Dis. 2015 Aug;55(2):187-8. doi: 10.1016/j.bcmd.2015.01.002. Epub 2015 Jan 17.

[Aplastic anemia].再生障碍性贫血

Dtsch Med Wochenschr. 2014 Dec;139(49):2503-6. doi: 10.1055/s-0034-1387407. Epub 2014 Nov 25.

[Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].[同种异体造血干细胞移植后移植物失败的二次移植——关东细胞治疗研究组的回顾性调查]

Rinsho Ketsueki. 2010 Jun;51(6):390-7.

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.系列嵌合体分析表明，混合造血嵌合体影响严重再生障碍性贫血（SAA）异基因干细胞移植（SCT）后移植物排斥和疾病复发的概率：SAA进行SCT后常规评估嵌合体的指征。

Br J Haematol. 2009 Mar;144(6):933-45. doi: 10.1111/j.1365-2141.2008.07533.x. Epub 2009 Jan 9.

TINF2 mutations in children with severe aplastic anemia.重型再生障碍性贫血患儿的TINF2突变

Pediatr Blood Cancer. 2009 May;52(5):687. doi: 10.1002/pbc.21903.

[Hematopoietic stem cell transplantation for acquired aplastic anemia].

Rinsho Ketsueki. 2015 Oct;56(10):2153-9. doi: 10.11406/rinketsu.56.2153.

Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia.嘌呤类似物预处理可提高免疫抑制后骨髓移植治疗再生障碍性贫血的植入率。

Biol Blood Marrow Transplant. 2013 Apr;19(4):584-8. doi: 10.1016/j.bbmt.2012.12.017. Epub 2012 Dec 25.

Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.以环磷酰胺和全身淋巴组织照射作为预处理方案进行再生障碍性贫血骨髓移植后的长期疗效。

Biol Blood Marrow Transplant. 2008 Jan;14(1):43-9. doi: 10.1016/j.bbmt.2007.06.015. Epub 2007 Dec 3.

Identification of TINF2 gene mutations in adult Japanese patients with acquired bone marrow failure syndromes.日本成年获得性骨髓衰竭综合征患者中TINF2基因突变的鉴定

Br J Haematol. 2010 Sep;150(6):725-7. doi: 10.1111/j.1365-2141.2010.08278.x.

Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.阿仑单抗、氟达拉滨和美法仑作为严重再生障碍性贫血和低增生性骨髓增生异常综合征的预处理疗法——单中心经验

Jpn J Clin Oncol. 2006 Jan;36(1):46-9. doi: 10.1093/jjco/hyi211. Epub 2006 Jan 19.

引用本文的文献

Hematopoietic stem cell transplantation of aplastic anemia by relative with mutations and normal telomere length: A case report.伴有突变且端粒长度正常的亲属对再生障碍性贫血患者进行造血干细胞移植：一例报告

World J Clin Cases. 2023 Oct 16;11(29):7200-7206. doi: 10.12998/wjcc.v11.i29.7200.

Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying a Variant.携带变异体的患者的自身免疫性中性粒细胞减少症和免疫失调

Int J Mol Sci. 2022 Nov 22;23(23):14535. doi: 10.3390/ijms232314535.

TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis.一名肺纤维化患者的TINF2基因突变

Case Rep Pulmonol. 2016;2016:1310862. doi: 10.1155/2016/1310862. Epub 2016 Mar 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验